Original article
Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders
S Oertle, H Mauron, PN Villiger
This text is only available as PDF .
This text is only available as PDF .